In particular, Notch2 was reported to display a weak expression at the protein level in 11 cases of GBM samples (Dell'Albani et al., 2014), which is different from our results that over half of GBM samples (80%, 56/70) presented with a high expression of Notch2. This evidence concerns the gene NOTCH2 and glioblastoma.